Surgical Science Schedules Q3 Interim Report Conference Call
Surgical Science Sweden AB invites attendees to a conference call regarding its Q3 interim report.
Related stories
Shadowfax Q2 Profit Rises to ₹68 Crore as Revenue Grows 57%
Shadowfax Technologies reported net profit of ₹68 crore for the September quarter, up from ₹13 crore a year earlier. Revenue grew 57% year on year.
M impact | EQUITY | Oct 29, 2026, 09:16 AM UTC
Beijing Capital Development Reports Q3 Net Loss of 1.1 Billion Yuan
M impact | EQUITY | Oct 29, 2026, 09:16 AM UTC
Apar Industries Shares Gain 5% After Q2 Profit and EBITDA Beat Estimates
Apar Industries reported second-quarter profit after tax of ₹447 crore, versus a CNBC-TV18 poll estimate of ₹339 crore and ₹51.7 crore a year earlier. Shares gained 5%, and margins
M impact | EQUITY | Oct 29, 2026, 09:16 AM UTC
Senores Pharmaceuticals Shares Fall 3% as Q2 Profit Rises 22%, Revenue 25%
Senores Pharmaceuticals shares fell 3% despite increases in quarterly profit and revenue. The body says results were for the quarter ended in September 2026.
M impact | EQUITY | Oct 29, 2026, 09:16 AM UTC
Dashenlin Pharmaceutical Q3 Net Profit Rises 21.7% Y/Y
M impact | EQUITY | Oct 29, 2026, 09:16 AM UTC
Haleon CEO Says China Centrum OTC Issue May Persist Through 2027
Haleon is working to mitigate the China Centrum OTC issue through portfolio changes in China.
L impact | EQUITY | Oct 29, 2026, 09:16 AM UTC